Zhenwu decoction ameliorates adriamycin-induced nephrotic syndrome in rats via dual modulation of AVP-V2R-AQP2 and RAAS-MR-AQP3 pathways
Mengmeng Xu, Min Du, Wanying Qu, Yanjun Wei, Hui Wang, Xin Yang · 2025
Read Zhenwu decoction ameliorates adriamycin-induced nephrotic syndrome in rats via dual modulation of AVP-V2R-AQP2 and RAAS-MR-AQP3 pathways by Mengmeng Xu, Min Du, Wanying Qu, Yanjun Wei, Hui Wang, Xin Yang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12713216.txt.
Description
Mengmeng Xu and co-authors test a traditional herbal mix in rats with kidney disease in a 2025 study. Zhenwu decoction is used for kidney problems, but its active parts and its action on swelling were not clear. Rats get a drug that triggers nephrotic syndrome, then the decoction at three doses or a standard steroid for four weeks.
The decoction cuts protein loss in urine by more than half, the team reports. Kidney tissue damage and scarring ease, and several blood measures improve. Levels of water control hormones fall, and three water channel proteins in the kidney drop. Two hormone pathways seem to carry the effect.
Catalog record
| CREATOR | Mengmeng Xu, Min Du, Wanying Qu, Yanjun Wei, Hui Wang, Xin Yang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |